Noticias y Actividades de Sangamo Therapeutics

Sangamo Therapeutics es una de las ...

• Russell 3000;
• TOB Iconic 10,000.

Sangamo Therapeutics es una empresa que cotiza bajo el símbolo de cotización SGMO (US).

Ver el organigrama con sus 18 ejecutivos principales

Biografías más buscadas en Sangamo Therapeutics

• Alexander Macrae, Director, President and Chief Executive Officer
• Robert Carey, Director
• Stewart Parker, Chairman of the Board

Crear su alerta
para seguir los movimientos de los ejecutivos en Sangamo Therapeutics.

Sangamo Therapeutics tiene 1.833 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Eli Lilly (Estados Unidos).

Popular M&A news in Farmacia

• Imbria Pharmaceuticals acaba de anunciar una recaudación de fondos de 58 millones de dólares. (publicado el 10 de abril de 2025).
• Clario ha NRx Pharmaceuticals adquirido (publicado el 18 de marzo de 2025).
• Knight Therapeutics has announced the acquisition of Paladin Labs  (publicado el 12 de marzo de 2025).

Otros contactos sugeridos en el sector Farmacia

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets en Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer en Adare Pharmaceuticals
• Paul Meister - Chairman of the Board en Amneal Pharmaceuticals

Saber más sobre el sector Farmacia

Últimos comunicados de prensa de Sangamo Therapeutics

• Sangamo Therapeutics Announces Second Quarter 2022 Conference Call and Webcast | Sangamo Therapeutics, Inc.
• European Orphan Medicinal Product Designation Granted to Sangamo Therapeutics Investigational CAR-Treg Cell Therapy TX200 for Solid Organ Transplantation | Sangamo Therapeutics, Inc.
• News Releases | Sangamo Therapeutics, Inc.
• News Releases | Sangamo Therapeutics, Inc.
• Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences | Sangamo Therapeutics, Inc.
• Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results | Sangamo Therapeutics, Inc.
• Sangamo Therapeutics to Present Data From Its Next-Generation Technologies at 2022 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) | Sangamo Therapeutics, Inc.
• Sangamo Therapeutics Announces First Quarter 2022 Conference Call and Webcast | Sangamo Therapeutics, Inc.
• News Releases | Investor Relations | Sangamo Therapeutics, Inc.
• Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment | Sangamo Therapeutics, Inc.
• View more press releases Close

Redes sociales sobre Sangamo Therapeutics

• Sangamo Therapeutics en Wikipedia, Google News y Yahoo Finance
• Sangamo Therapeutics en LinkedIn, Twitter y YouTube